Spastic Cerebral Palsy (SCP)
Spastic cerebral palsy is the type of cerebral palsy wherein spasticity is the exclusive impairment present. It affects the cerebral cortex.
It is by far the most common type of overall cerebral palsy. Occurring in 90% of all cases according to the Society for Cerebral Palsy in Europe (SCPE); even if the 90% assertion is an exaggeration; however, more conservative scientific estimates still place the prevalence of spasticity-dominant cerebral palsy at anywhere from 70–80% of all cases, leaving cases dominated by ataxic cerebral palsy, dyskinetic cerebral palsy and athetoid cerebral palsy trailing at 20–30%.
Organism species: Pan-species (General)
|PRODUCT TYPE||CATALOG NO.||PRODUCT NAME||APPLICATIONS|
|Proteins||N/A||Recombinant Spastic Cerebral Palsy (SCP)||Antigenic Transformation Customized Service Offer|
|Antibodies||N/A||Monoclonal Antibody to Spastic Cerebral Palsy (SCP)||Monoclonal Antibody Customized Service Offer|
|N/A||Polyclonal Antibody to Spastic Cerebral Palsy (SCP)||Polyclonal Antibody Customized Service Offer|
|Assay Kits||N/A||CLIA Kit for Spastic Cerebral Palsy (SCP)||CLIA Kit Customized Service Offer|
|N/A||ELISA Kit for Spastic Cerebral Palsy (SCP)||ELISA Kit Customized Service Offer|